Aktie A2DS3X ADVANCED ENZYME TECHNOLOGIES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Advanced Enzyme Technologies Limited Bombay S.E.

Aktien

A2DS3X

INE837H01020

ADVENZYMES

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:00:50 03.05.2024 		% 5 Tage % 1. Jan.
394,2 INR -0,34 % Intraday Chart für Advanced Enzyme Technologies Limited +0,68 % +5,04 %
30.03. Advanced Enzyme Technologies Limited gibt das Ausscheiden von Kedar J. Desai als unabhängiges Verwaltungsratsmitglied bekannt CI
06.03. Advanced Enzyme schließt Erwerb eines zusätzlichen Anteils von 5,9% an der Tochtergesellschaft JC Biotech ab MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Advanced Enzyme Technologies Limited Announces Cessation of Kedar J. Desai as Independent Director
Advanced Enzyme Completes Acquisition of Additional 5.9% Stake in Subsidiary JC Biotech
Advanced Enzyme Technologies Limited acquired additional 5.89% stake in Jc Biotech Private Limited for INR 56.1 million
Advanced Enzyme Technologies to Lift Stake in JC Biotech to Nearly 96%
Advanced Enzyme Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Advanced Enzyme Technologies Limited agreed to acquire additional 5.89% stake in Jc Biotech Private Limited for INR 56.1 million.
Crisil Keeps A+ Rating on Advanced Enzyme Technologies' Bank Loans; Outlook Stable
Advanced Enzyme Technologies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Advanced Enzyme Technologies Declares Final Dividend for the Financial Year Ended March 31, 2023
Advanced Enzyme Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Advanced Enzyme Technologies Limited Proposes Dividend Payable on or After August 16, 2023
Advanced Enzyme Technologies Limited Announces Board Changes
Advanced Enzyme Technologies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Advanced Enzyme Technologies Limited Recommends Final Dividend for the Financial Year 2022-23; Declares an Interim Dividend for the Financial Year 2023-24, Payable on or Before June 11, 2023
Advanced Enzyme Technologies' Overseas Units Get Board Nod for Proposed Merger
Advanced Enzyme Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Advanced Enzyme Completes Acquisition of Stakes in Saiganesh Enzytech, JC Biotech
Advanced Enzyme Technologies Limited completed the acquisition of additional 4.83% stake in JC Biotech Private Limited.
Advanced Enzyme Technologies Limited agreed to acquire additional 4.83% stake in JC Biotech Private Limited for INR 68 million.
Advanced Enzyme Technologies : Adecco says revenues continue to fall at start of second quarter
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2DS3X Aktie
  4. A2DS3X Aktie
  5. Nachrichten Advanced Enzyme Technologies Limited
  6. Andere Sprachen